CA
NZ
UK
AU
IND
US
Russel Harold McMeekin, Global Corporate President of OpenWorld, Inc. (NASDAQ:OPNW), filed a Form 4 on November 9, 2026, disclosing a stock option amendment transaction dated November 5, 2026, in which an outstanding option was canceled and replaced with a new option at a revised …
Christopher Lawrence Bennett, Chief Legal Officer of Six Flags Entertainment Corporation, filed a Form 4 on November 9, 2026, disclosing an open-market purchase of common stock on November 6, 2026.
Gerard Albert Palana Hernandez, Chief Financial Officer of OpenWorld, Inc. (NASDAQ:OPNW), filed a Form 4 on November 9, 2026, disclosing a stock option amendment and his current beneficial ownership of company securities as of November 5, 2026.
Director Timothy S. Cabral filed a Form 4 with the SEC on November 9, 2026, reporting transactions in Doximity, Inc. (NYSE:DOCS) Class A and Class B Common Stock dated November 5, 2026.
Richard M. Schulze, Chairman Emeritus of Best Buy Co Inc, filed a Form 4 on November 9, 2026, disclosing a change in beneficial ownership of common stock resulting from the appointment of his spouse as trustee of a trust on November 5, 2026.
Carlos Nueno, President, International at Teladoc Health, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 29,432 shares of common stock on November 6, 2026, under a pre-established Rule 10b5-1 trading plan.
Director and 10% owner Edgar R. Smith III filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 5,000 shares of First Guaranty Bancshares, Inc. common stock on November 6, 2026.
A Form 4 filed on November 9, 2026 reports that Beth Bruce Witte, a director of Slide Insurance Holdings, Inc. (NASDAQ:SLDE), sold 25,000 shares of common stock on November 5, 2026 through the Beth W. Bruce Witte Family 1992 Trust.
Juan Andres, Chief Operating Officer of Moderna, Inc., filed a Form 4 on November 9, 2026, disclosing the acquisition of stock options and restricted stock units on November 5, 2026 under NASDAQ:MRNA.
Director Joel Ackerman of Champions Oncology, Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of options to purchase 31,216 shares of common stock on November 5, 2026.
Please wait processing your request...